detected circulating S1 in the plasma of COVID-19 patients and showed that higher concentrations of S1 correlated with COVID-19 severity (49), potentially due to increased exposure to the SARS-CoV-2 SAg-like motif. Here, PSMD1 is linked to COVID-19.